Japanese Billionaire Masayoshi Son’s Investments: Top 5 Stock Picks

Page 1 of 5

In this piece, we will take a look at Japanese billionaire Masayoshi Son’s investments: Top 5 stock picks. If you want to take a detailed look at Mr. Son’s top 10 companies and his investment firm, then head on to Japanese Billionaire Masayoshi Son’s Investments: Top 10 Stock Picks.

5. Sana Biotechnology, Inc. (NASDAQ:SANA)

SB Management’s holdings: $49.7 million

Percentage of SB Management’s Portfolio: 5.09%

Number of Hedge Fund Holders: 7

Sana Biotechnology, Inc. (NASDAQ:SANA) is an American cell engineering firm. Its cells, which refer to those present in the human body, target diseases such as diabetes, heart diseases, and nervous system disorders.

Mr. Son’s SB Management held 2.2 million Sana Biotechnology, Inc. (NASDAQ:SANA) shares as of the third quarter of 2021. These are worth $49.7 million and represent 5.09% of the firm’s portfolio. Out of the 867 hedge funds surveyed by Insider Monkey at Q3 2021 end, 7 held a stake in the company.

Sana Biotechnology, Inc. (NASDAQ:SANA) reported -$0.46 in GAAP EPS for its third quarter. In a March 2021 analyst note, Morgan Stanley set a $40 price target for the company, touting its disruptive abilities to replace dead cells in patients.

Sana Biotechnology, Inc. (NASDAQ:SANA)’s largest shareholder after SB Management is Jane Mendillo’s Harvard Management Co who holds 1.1 million shares worth $26 million.

Page 1 of 5